pomalidomide has been researched along with Sensitivity and Specificity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Byrd, JC; Chen, CS; Hofmeister, CC; Jiang, Y; Johnson, AJ; Kolli, S; Phelps, MA; Rozewski, DM; Wang, J; Wu, CH; Yang, X | 1 |
| Aleman, K; Figg, WD; Peer, CJ; Polizzotto, MN; Roth, J; Shahbazi, S; Uldrick, TS; Wyvill, KM; Yarchoan, R; Zeldis, JB | 1 |
2 other study(ies) available for pomalidomide and Sensitivity and Specificity
| Article | Year |
|---|---|
Sensitive liquid chromatography/mass spectrometry methods for quantification of pomalidomide in mouse plasma and brain tissue.
Topics: Animals; Brain; Chromatography, Liquid; Immunologic Factors; Linear Models; Mice; Quality Control; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Thalidomide; Tissue Distribution | 2014 |
A sensitive and robust HPLC assay with fluorescence detection for the quantification of pomalidomide in human plasma for pharmacokinetic analyses.
Topics: Biological Assay; Chromatography, High Pressure Liquid; Drug Stability; Fluorescence; Humans; Liquid-Liquid Extraction; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Fluorescence; Thalidomide | 2014 |